2020 ICD-10-CM Diagnosis Code D68.312

Antiphospholipid antibody with hemorrhagic disorder

    2016 2017 2018 2019 2020 Billable/Specific Code
  • D68.312 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2020 edition of ICD-10-CM D68.312 became effective on October 1, 2019.
  • This is the American ICD-10-CM version of D68.312 - other international versions of ICD-10 D68.312 may differ.
Applicable To
  • Lupus anticoagulant (LAC) with hemorrhagic disorder
  • Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D68.312. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • antiphospholipid antibody, finding without diagnosis (
    ICD-10-CM Diagnosis Code R76.0

    Raised antibody titer

      2016 2017 2018 2019 2020 Billable/Specific Code
    Type 1 Excludes
    • isoimmunization in pregnancy (O36.0-O36.1)
    • isoimmunization affecting newborn (P55.-)
    R76.0
    )
  • antiphospholipid antibody syndrome (
    ICD-10-CM Diagnosis Code D68.61

    Antiphospholipid syndrome

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Anticardiolipin syndrome
    • Antiphospholipid antibody syndrome
    Type 1 Excludes
    • anti-phospholipid antibody, finding without diagnosis (R76.0)
    • anti-phospholipid antibody with hemorrhagic disorder (D68.312)
    • lupus anticoagulant syndrome (D68.62)
    D68.61
    )
  • antiphospholipid antibody with hypercoagulable state (
    ICD-10-CM Diagnosis Code D68.61

    Antiphospholipid syndrome

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Anticardiolipin syndrome
    • Antiphospholipid antibody syndrome
    Type 1 Excludes
    • anti-phospholipid antibody, finding without diagnosis (R76.0)
    • anti-phospholipid antibody with hemorrhagic disorder (D68.312)
    • lupus anticoagulant syndrome (D68.62)
    D68.61
    )
  • lupus anticoagulant (LAC) finding without diagnosis (
    ICD-10-CM Diagnosis Code R76.0

    Raised antibody titer

      2016 2017 2018 2019 2020 Billable/Specific Code
    Type 1 Excludes
    • isoimmunization in pregnancy (O36.0-O36.1)
    • isoimmunization affecting newborn (P55.-)
    R76.0
    )
  • lupus anticoagulant (LAC) with hypercoagulable state (
    ICD-10-CM Diagnosis Code D68.62

    Lupus anticoagulant syndrome

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Lupus anticoagulant
    • Presence of systemic lupus erythematosus [SLE] inhibitor
    Type 1 Excludes
    • anticardiolipin syndrome (D68.61)
    • antiphospholipid syndrome (D68.61)
    • lupus anticoagulant (LAC) finding without diagnosis (R76.0)
    • lupus anticoagulant (LAC) with hemorrhagic disorder (D68.312)
    D68.62
    )
  • systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (
    ICD-10-CM Diagnosis Code R76.0

    Raised antibody titer

      2016 2017 2018 2019 2020 Billable/Specific Code
    Type 1 Excludes
    • isoimmunization in pregnancy (O36.0-O36.1)
    • isoimmunization affecting newborn (P55.-)
    R76.0
    )
  • systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (
    ICD-10-CM Diagnosis Code D68.62

    Lupus anticoagulant syndrome

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Lupus anticoagulant
    • Presence of systemic lupus erythematosus [SLE] inhibitor
    Type 1 Excludes
    • anticardiolipin syndrome (D68.61)
    • antiphospholipid syndrome (D68.61)
    • lupus anticoagulant (LAC) finding without diagnosis (R76.0)
    • lupus anticoagulant (LAC) with hemorrhagic disorder (D68.312)
    D68.62
    )
The following code(s) above D68.312 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D68.312:
  • D50-D89
    2020 ICD-10-CM Range D50-D89

    Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

    Type 2 Excludes
    • autoimmune disease (systemic) NOS (M35.9)
    • certain conditions originating in the perinatal period (P00-P96)
    • complications of pregnancy, childbirth and the puerperium (O00-O9A)
    • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
    • endocrine, nutritional and metabolic diseases (E00-E88)
    • human immunodeficiency virus [HIV] disease (B20)
    • injury, poisoning and certain other consequences of external causes (S00-T88)
    • neoplasms (C00-D49)
    • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
    Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
  • D68
    ICD-10-CM Diagnosis Code D68

    Other coagulation defects

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • abnormal coagulation profile (R79.1)
    • coagulation defects complicating abortion or ectopic or molar pregnancy (O00-O07, O08.1)
    • coagulation defects complicating pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)
    Other coagulation defects
ICD-10-CM D68.312 is grouped within Diagnostic Related Group(s) (MS-DRG v37.0):
  • 814 Reticuloendothelial and immunity disorders with mcc
  • 815 Reticuloendothelial and immunity disorders with cc
  • 816 Reticuloendothelial and immunity disorders without cc/mcc

Convert D68.312 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
Code annotations containing back-references to D68.312:
  • Type 1 Excludes: D68.61
    , D68.62
    , D68.5
    ICD-10-CM Diagnosis Code D68.61

    Antiphospholipid syndrome

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Anticardiolipin syndrome
    • Antiphospholipid antibody syndrome
    Type 1 Excludes
    • anti-phospholipid antibody, finding without diagnosis (R76.0)
    • anti-phospholipid antibody with hemorrhagic disorder (D68.312)
    • lupus anticoagulant syndrome (D68.62)
    ICD-10-CM Diagnosis Code D68.62

    Lupus anticoagulant syndrome

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Lupus anticoagulant
    • Presence of systemic lupus erythematosus [SLE] inhibitor
    Type 1 Excludes
    • anticardiolipin syndrome (D68.61)
    • antiphospholipid syndrome (D68.61)
    • lupus anticoagulant (LAC) finding without diagnosis (R76.0)
    • lupus anticoagulant (LAC) with hemorrhagic disorder (D68.312)
    ICD-10-CM Diagnosis Code D68.5

    Primary thrombophilia

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Applicable To
    • Primary hypercoagulable states
    Type 1 Excludes
    • antiphospholipid syndrome (D68.61)
    • lupus anticoagulant (D68.62)
    • secondary activated protein C resistance (D68.69)
    • secondary antiphospholipid antibody syndrome (D68.69)
    • secondary lupus anticoagulant with hypercoagulable state (D68.69)
    • secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
    • systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
    • systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)
    • thrombotic thrombocytopenic purpura (M31.1)

Diagnosis Index entries containing back-references to D68.312:
  • Antibody
    • anticardiolipin R76.0
      ICD-10-CM Diagnosis Code R76.0

      Raised antibody titer

        2016 2017 2018 2019 2020 Billable/Specific Code
      Type 1 Excludes
      • isoimmunization in pregnancy (O36.0-O36.1)
      • isoimmunization affecting newborn (P55.-)
      • with
        • hemorrhagic disorder D68.312
    • antiphosphatidylglycerol R76.0
      ICD-10-CM Diagnosis Code R76.0

      Raised antibody titer

        2016 2017 2018 2019 2020 Billable/Specific Code
      Type 1 Excludes
      • isoimmunization in pregnancy (O36.0-O36.1)
      • isoimmunization affecting newborn (P55.-)
      • with
        • hemorrhagic disorder D68.312
    • antiphosphatidylinositol R76.0
      ICD-10-CM Diagnosis Code R76.0

      Raised antibody titer

        2016 2017 2018 2019 2020 Billable/Specific Code
      Type 1 Excludes
      • isoimmunization in pregnancy (O36.0-O36.1)
      • isoimmunization affecting newborn (P55.-)
      • with
        • hemorrhagic disorder D68.312
    • antiphosphatidylserine R76.0
      ICD-10-CM Diagnosis Code R76.0

      Raised antibody titer

        2016 2017 2018 2019 2020 Billable/Specific Code
      Type 1 Excludes
      • isoimmunization in pregnancy (O36.0-O36.1)
      • isoimmunization affecting newborn (P55.-)
      • with
        • hemorrhagic disorder D68.312
    • antiphospholipid R76.0
      ICD-10-CM Diagnosis Code R76.0

      Raised antibody titer

        2016 2017 2018 2019 2020 Billable/Specific Code
      Type 1 Excludes
      • isoimmunization in pregnancy (O36.0-O36.1)
      • isoimmunization affecting newborn (P55.-)
      • with
        • hemorrhagic disorder D68.312
  • Antiphospholipid
    • antibody
      • with hemorrhagic disorder D68.312
  • Lupus
    • anticoagulant D68.62
      ICD-10-CM Diagnosis Code D68.62

      Lupus anticoagulant syndrome

        2016 2017 2018 2019 2020 Billable/Specific Code
      Applicable To
      • Lupus anticoagulant
      • Presence of systemic lupus erythematosus [SLE] inhibitor
      Type 1 Excludes
      • anticardiolipin syndrome (D68.61)
      • antiphospholipid syndrome (D68.61)
      • lupus anticoagulant (LAC) finding without diagnosis (R76.0)
      • lupus anticoagulant (LAC) with hemorrhagic disorder (D68.312)
      • with
        • hemorrhagic disorder D68.312
    • erythematosus (discoid) (local) L93.0
      ICD-10-CM Diagnosis Code L93.0

      Discoid lupus erythematosus

        2016 2017 2018 2019 2020 Billable/Specific Code
      Applicable To
      • Lupus erythematosus NOS
      • systemic M32.9
        ICD-10-CM Diagnosis Code M32.9

        Systemic lupus erythematosus, unspecified

          2016 2017 2018 2019 2020 Billable/Specific Code
        Applicable To
        • SLE NOS
        • Systemic lupus erythematosus NOS
        • Systemic lupus erythematosus without organ involvement
        • inhibitor (presence of) D68.62
          ICD-10-CM Diagnosis Code D68.62

          Lupus anticoagulant syndrome

            2016 2017 2018 2019 2020 Billable/Specific Code
          Applicable To
          • Lupus anticoagulant
          • Presence of systemic lupus erythematosus [SLE] inhibitor
          Type 1 Excludes
          • anticardiolipin syndrome (D68.61)
          • antiphospholipid syndrome (D68.61)
          • lupus anticoagulant (LAC) finding without diagnosis (R76.0)
          • lupus anticoagulant (LAC) with hemorrhagic disorder (D68.312)
          • with
            • hemorrhagic disorder D68.312

ICD-10-CM Codes Adjacent To D68.312
D65 Disseminated intravascular coagulation [defibrination syndrome]
D66 Hereditary factor VIII deficiency
D67 Hereditary factor IX deficiency
D68 Other coagulation defects
D68.0 Von Willebrand's disease
D68.1 Hereditary factor XI deficiency
D68.2 Hereditary deficiency of other clotting factors
D68.3 Hemorrhagic disorder due to circulating anticoagulants
D68.31 Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
D68.311 Acquired hemophilia
D68.312 Antiphospholipid antibody with hemorrhagic disorder
D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
D68.4 Acquired coagulation factor deficiency
D68.5 Primary thrombophilia
D68.51 Activated protein C resistance
D68.52 Prothrombin gene mutation
D68.59 Other primary thrombophilia
D68.6 Other thrombophilia
D68.61 Antiphospholipid syndrome
D68.62 Lupus anticoagulant syndrome

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.